Heron Therapeutics

-$0.15 (-1.22%) As of 3:44 PM UTC today

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell HRTX and other ETFs, options, and stocks.

About HRTX

Heron Therapeutics, Inc. is a biotechnology company, which engages in the development of pharmaceutical products for patients suffering from cancer. Its products portfolio include SUSTOL, Cinvanti, HTX-011 and HTX-034.

CEO
Barry D. Quart
Employees
223
Headquarters
San Diego, California
Founded
1983

HRTX Key Statistics

Market Cap
1.37B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
1.38M
High Today
$12.40
Low Today
$12.17
Open Price
$12.33
Volume
253.10K
52 Week High
$22.40
52 Week Low
$12.17

HRTX Earnings

-$0.68
-$0.45
-$0.23
$0.00
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Estimated
— per share
Actual
Expected Aug 5, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure